| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:54 UTC |
|---|
| HMDB ID | HMDB0015220 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Iloprost |
|---|
| Description | Iloprost is only found in individuals that have used or taken this drug. It is a synthetic analogue of prostacyclin PGI2. Iloprost dilates systemic and pulmonary arterial vascular beds. It is used to treat pulmonary arterial hypertension (PAH).Iloprost is a second generation structural analog of prostacyclin (PGI) with about ten-fold greater potency than the first generation stable analogs, such as carbaprostacyclin. Iloprost binds with equal affinity to human prostacyclin (Prostanoid IP) and prostaglandin EP1 receptors. Iloprost constricts the ilium and fundus circular smooth muscle as strongly as prostaglandin E2 (PGE2) itself. Iloprost inhibits the ADP, thrombin, and collagen-induced aggregation of human platelets. In whole animals, iloprost acts as a vasodilator, hypotensive, antidiuretic, and prolongs bleeding time. All of these properties help to antagonize the pathological changes that take place in the small pulmonary arteries of patients with pulmonary hypertension. |
|---|
| Structure | CC#CCC(C)C(O)\C=C\C1C(O)CC2C\C(CC12)=C\CCCC(=O)OCC(=O)C1=CC=CC=C1 InChI=1S/C30H38O5/c1-3-4-10-21(2)27(31)16-15-25-26-18-22(17-24(26)19-28(25)32)11-8-9-14-30(34)35-20-29(33)23-12-6-5-7-13-23/h5-7,11-13,15-16,21,24-28,31-32H,8-10,14,17-20H2,1-2H3/b16-15+,22-11- |
|---|
| Synonyms | | Value | Source |
|---|
| Iloprost-pe | HMDB | | 2-oxo-2-Phenylethyl 5-[(2Z)-5-hydroxy-4-[(1E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]-octahydropentalen-2-ylidene]pentanoic acid | HMDB | | Iloprost phenacyl ester | HMDB |
|
|---|
| Chemical Formula | C30H38O5 |
|---|
| Average Molecular Weight | 478.6197 |
|---|
| Monoisotopic Molecular Weight | 478.271924326 |
|---|
| IUPAC Name | 2-oxo-2-phenylethyl 5-[(2Z)-5-hydroxy-4-[(1E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]-octahydropentalen-2-ylidene]pentanoate |
|---|
| Traditional Name | iloprost |
|---|
| CAS Registry Number | 78919-13-8 |
|---|
| SMILES | CC#CCC(C)C(O)\C=C\C1C(O)CC2C\C(CC12)=C\CCCC(=O)OCC(=O)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C30H38O5/c1-3-4-10-21(2)27(31)16-15-25-26-18-22(17-24(26)19-28(25)32)11-8-9-14-30(34)35-20-29(33)23-12-6-5-7-13-23/h5-7,11-13,15-16,21,24-28,31-32H,8-10,14,17-20H2,1-2H3/b16-15+,22-11- |
|---|
| InChI Key | CZUMMMDKQYRZDP-JCAXBLPDSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Eicosanoids |
|---|
| Direct Parent | Prostaglandins and related compounds |
|---|
| Alternative Parents | |
|---|
| Substituents | - Prostaglandin skeleton
- Alkyl-phenylketone
- Aromatic monoterpenoid
- Monoterpenoid
- Bicyclic monoterpenoid
- Phenylketone
- Fatty alcohol
- Benzoyl
- Aryl alkyl ketone
- Aryl ketone
- Fatty acid ester
- Alpha-acyloxy ketone
- Monocyclic benzene moiety
- Benzenoid
- Cyclic alcohol
- Ketone
- Carboxylic acid ester
- Secondary alcohol
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Carbonyl group
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Alcohol
- Aromatic homopolycyclic compound
|
|---|
| Molecular Framework | Aromatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.002 g/L | Not Available | | LogP | 4.8 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.47 minutes | 32390414 | | Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.16 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 17.5803 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.51 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 46.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3343.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 272.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 238.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 181.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 252.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 801.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 707.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 86.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1556.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 665.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1729.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 477.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 453.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 222.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 298.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Iloprost,1TMS,isomer #1 | CC#CCC(C)C(/C=C/C1C(O)CC2C/C(=C/CCCC(=O)OCC(=O)C3=CC=CC=C3)CC21)O[Si](C)(C)C | 3960.3 | Semi standard non polar | 33892256 | | Iloprost,1TMS,isomer #2 | CC#CCC(C)C(O)/C=C/C1C(O[Si](C)(C)C)CC2C/C(=C/CCCC(=O)OCC(=O)C3=CC=CC=C3)CC21 | 3895.7 | Semi standard non polar | 33892256 | | Iloprost,2TMS,isomer #1 | CC#CCC(C)C(/C=C/C1C(O[Si](C)(C)C)CC2C/C(=C/CCCC(=O)OCC(=O)C3=CC=CC=C3)CC21)O[Si](C)(C)C | 3835.6 | Semi standard non polar | 33892256 | | Iloprost,1TBDMS,isomer #1 | CC#CCC(C)C(/C=C/C1C(O)CC2C/C(=C/CCCC(=O)OCC(=O)C3=CC=CC=C3)CC21)O[Si](C)(C)C(C)(C)C | 4186.1 | Semi standard non polar | 33892256 | | Iloprost,1TBDMS,isomer #2 | CC#CCC(C)C(O)/C=C/C1C(O[Si](C)(C)C(C)(C)C)CC2C/C(=C/CCCC(=O)OCC(=O)C3=CC=CC=C3)CC21 | 4126.1 | Semi standard non polar | 33892256 | | Iloprost,2TBDMS,isomer #1 | CC#CCC(C)C(/C=C/C1C(O[Si](C)(C)C(C)(C)C)CC2C/C(=C/CCCC(=O)OCC(=O)C3=CC=CC=C3)CC21)O[Si](C)(C)C(C)(C)C | 4269.9 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Iloprost GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-3953200000-b443b1bda7d785ac5d30 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Iloprost GC-MS (2 TMS) - 70eV, Positive | splash10-0a4i-1900210000-4e1ef34a133a2751758b | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Iloprost GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Iloprost GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 10V, Positive-QTOF | splash10-03fu-0002900000-6a96f6c0e27208aa18ae | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 20V, Positive-QTOF | splash10-01yc-5455900000-87ae1678bc484e678de9 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 40V, Positive-QTOF | splash10-057i-9483100000-98e240ce9fc267005932 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 10V, Negative-QTOF | splash10-004l-0105900000-bd6afd767ba75381c69a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 20V, Negative-QTOF | splash10-056u-5509500000-2084dc240e0f75394853 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 40V, Negative-QTOF | splash10-004i-9413000000-b2178e58ccb54de33168 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 10V, Positive-QTOF | splash10-004i-0017900000-5e1366159937b37e0b05 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 20V, Positive-QTOF | splash10-0aor-5308900000-271908350c9d4b1e9c90 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 40V, Positive-QTOF | splash10-0udu-9204300000-168e9fb8385284dbfa8a | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 10V, Negative-QTOF | splash10-056r-0102900000-10e1eb3ea58023970cd4 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 20V, Negative-QTOF | splash10-014i-7903300000-97e90a9cce893500efab | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Iloprost 40V, Negative-QTOF | splash10-054k-7194400000-f7eb359410db7895850e | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|